Nanexa signs Collaboration Agreement with Applied Materials, Inc.
Kurs & Likviditet
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Nanexa AB (publ) today announced that the company has entered into a collaboration agreement with the leading materials engineering solutions company Applied Materials, Inc. in order to establish a scaled-up GMP production site for ALD-coated pharmaceuticals located at Nanexa’s facilities in Uppsala.
“We are thrilled to work with Applied Materials for this crucial step in our development,” said David Westberg, CEO of Nanexa. “With this collaboration, we hope to broaden Nanexa’s business in the pharmaceutical field and strengthen our ability to rapidly scale up drug manufacturing for major clinical II/III trials, such as our own project NEX-18, and in the long run, establish industrial production capacity.”
Applied Materials is the global leader in materials engineering solutions used to produce virtually every new chip and advanced display in the world. Under this collaboration agreement Applied Materials will provide pilot manufacturing and engineering capabilities at Nanexa's GMP-classified facility in Uppsala.
Within the framework of the collaboration Nanexa will co-develop coating technology with an aim to scale-up the process for long-acting injectables.
“We are excited by the potential of bringing Applied’s deep expertise in materials engineering and advanced manufacturing technologies from the semiconductor industry to solve key challenges in life sciences,” said Om Nalamasu, President of Applied Ventures and CTO of Applied Materials. “We are delighted to work with Nanexa to employ nanometer scale coatings on active pharmaceutical ingredients for long-acting injectables. This collaboration adds to our expanding interests in life sciences and our ability to build cross-industry collaborations to extend innovations from the semiconductor industry to advancements in human health.”